1-181483778-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001205293.3(CACNA1E):​c.34C>T​(p.Pro12Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,459,182 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. P12P) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

CACNA1E
NM_001205293.3 missense

Scores

6
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.653
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.14114398).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ENM_001205293.3 linkc.34C>T p.Pro12Ser missense_variant Exon 1 of 48 ENST00000367573.7 NP_001192222.1 Q15878-1Q59FG1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1EENST00000367573.7 linkc.34C>T p.Pro12Ser missense_variant Exon 1 of 48 1 NM_001205293.3 ENSP00000356545.2 Q15878-1
CACNA1EENST00000360108.7 linkc.34C>T p.Pro12Ser missense_variant Exon 1 of 47 5 ENSP00000353222.3 F8W9Z1
CACNA1EENST00000367570.6 linkc.34C>T p.Pro12Ser missense_variant Exon 1 of 47 1 ENSP00000356542.1 Q15878-3
CACNA1EENST00000621791.4 linkc.34C>T p.Pro12Ser missense_variant Exon 1 of 46 1 ENSP00000481619.1 Q15878-2
CACNA1EENST00000524607.6 linkc.469C>T p.Pro157Ser missense_variant Exon 3 of 12 5 ENSP00000432038.2 E9PIE8

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
6.85e-7
AC:
1
AN:
1459182
Hom.:
0
Cov.:
31
AF XY:
0.00000138
AC XY:
1
AN XY:
725804
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33410
American (AMR)
AF:
0.00
AC:
0
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26072
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39662
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86134
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53304
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4922
European-Non Finnish (NFE)
AF:
9.00e-7
AC:
1
AN:
1110792
Other (OTH)
AF:
0.00
AC:
0
AN:
60214
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Jun 12, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.34C>T (p.P12S) alteration is located in exon 1 (coding exon 1) of the CACNA1E gene. This alteration results from a C to T substitution at nucleotide position 34, causing the proline (P) at amino acid position 12 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Uncertain
0.11
D
BayesDel_noAF
Uncertain
-0.070
CADD
Uncertain
24
DANN
Benign
0.93
DEOGEN2
Benign
0.13
.;.;.;.;T;T;.;T;.
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.068
FATHMM_MKL
Benign
0.57
D
LIST_S2
Uncertain
0.89
D;.;.;D;.;D;D;D;D
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.14
T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.024
D
MutationAssessor
Benign
0.63
.;N;N;.;N;.;N;N;N
PhyloP100
0.65
PrimateAI
Uncertain
0.57
T
PROVEAN
Benign
-0.83
.;N;.;N;N;.;.;.;.
REVEL
Benign
0.26
Sift
Benign
0.49
.;T;.;T;T;.;.;.;.
Sift4G
Benign
0.56
.;T;T;T;T;T;T;T;T
Polyphen
0.034
.;B;.;.;.;.;B;.;.
Vest4
0.14, 0.16, 0.23, 0.27, 0.22, 0.26, 0.26, 0.28
MutPred
0.24
.;Gain of glycosylation at P12 (P = 0.0109);Gain of glycosylation at P12 (P = 0.0109);Gain of glycosylation at P12 (P = 0.0109);Gain of glycosylation at P12 (P = 0.0109);Gain of glycosylation at P12 (P = 0.0109);Gain of glycosylation at P12 (P = 0.0109);Gain of glycosylation at P12 (P = 0.0109);Gain of glycosylation at P12 (P = 0.0109);
MVP
0.72
MPC
1.8
ClinPred
0.28
T
GERP RS
5.3
PromoterAI
-0.051
Neutral
Varity_R
0.059
gMVP
0.35
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr1-181452914; API